641 related articles for article (PubMed ID: 15148507)
1. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
[TBL] [Abstract][Full Text] [Related]
2. Effects of peptide YY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels.
Adams SH; Won WB; Schonhoff SE; Leiter AB; Paterniti JR
Endocrinology; 2004 Nov; 145(11):4967-75. PubMed ID: 15284202
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of food intake in obese subjects by peptide YY3-36.
Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR
N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742
[TBL] [Abstract][Full Text] [Related]
4. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
[TBL] [Abstract][Full Text] [Related]
5. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
[TBL] [Abstract][Full Text] [Related]
6. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
Riediger T; Bothe C; Becskei C; Lutz TA
Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of the somatotrophic axis in the obese agouti mouse.
Martin NM; Houston PA; Patterson M; Sajedi A; Carmignac DF; Ghatei MA; Bloom SR; Small CJ
Int J Obes (Lond); 2006 Mar; 30(3):430-8. PubMed ID: 16172617
[TBL] [Abstract][Full Text] [Related]
8. Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice.
Hoggard N; Rayner DV; Johnston SL; Speakman JR
J Mol Endocrinol; 2004 Dec; 33(3):693-703. PubMed ID: 15591028
[TBL] [Abstract][Full Text] [Related]
9. Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway.
Leckstrom A; Kim ER; Wong D; Mizuno TM
Diabetes; 2009 Jan; 58(1):87-94. PubMed ID: 18984739
[TBL] [Abstract][Full Text] [Related]
10. Alterations in downstream mediators involved in central control of eating behavior in obese adolescents submitted to a multidisciplinary therapy.
Prado WL; Oyama LM; Lofrano-Prado MC; de Piano A; Stella SG; Nascimento CM; Carnier J; Caranti DA; Tock L; Tufik S; de Mello MT; Dâmaso AR
J Adolesc Health; 2011 Sep; 49(3):300-5. PubMed ID: 21856523
[TBL] [Abstract][Full Text] [Related]
11. Evidence that diet-induced hyperleptinemia, but not hypothalamic gliosis, causes ghrelin resistance in NPY/AgRP neurons of male mice.
Briggs DI; Lockie SH; Benzler J; Wu Q; Stark R; Reichenbach A; Hoy AJ; Lemus MB; Coleman HA; Parkington HC; Tups A; Andrews ZB
Endocrinology; 2014 Jul; 155(7):2411-22. PubMed ID: 24742194
[TBL] [Abstract][Full Text] [Related]
12. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome.
Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD
Mol Endocrinol; 1997 May; 11(5):630-7. PubMed ID: 9139806
[TBL] [Abstract][Full Text] [Related]
13. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
14. Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system.
Gout J; Sarafian D; Tirard J; Blondet A; Vigier M; Rajas F; Mithieux G; Begeot M; Naville D
Obesity (Silver Spring); 2008 Aug; 16(8):1763-9. PubMed ID: 18551122
[TBL] [Abstract][Full Text] [Related]
15. Effects of peripheral administration of PYY3-36 on feed intake and plasma acyl-ghrelin levels in pigs.
Ito T; Thidarmyint H; Murata T; Inoue H; Neyra RM; Kuwayama H
J Endocrinol; 2006 Oct; 191(1):113-9. PubMed ID: 17065394
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
[TBL] [Abstract][Full Text] [Related]
18. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people.
Vazquez Roque MI; Camilleri M; Stephens DA; Jensen MD; Burton DD; Baxter KL; Zinsmeister AR
Gastroenterology; 2006 Dec; 131(6):1717-24. PubMed ID: 17087952
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of transgenic melanocyte-stimulating hormone overexpression in lean and obese mice.
Savontaus E; Breen TL; Kim A; Yang LM; Chua SC; Wardlaw SL
Endocrinology; 2004 Aug; 145(8):3881-91. PubMed ID: 15117873
[TBL] [Abstract][Full Text] [Related]
20. Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism.
Halatchev IG; Ellacott KL; Fan W; Cone RD
Endocrinology; 2004 Jun; 145(6):2585-90. PubMed ID: 15016721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
